 Artist: Switches: mp3 download Genre(s): Indie Switches's discography:  Heart Tuned to Dead (Preview) Year: 2007 Tracks: 16 Playing tough, witty, and hook-laden harlan Stone that exists in a time deflection where glam rock and Britpop ar the peach of the British Isles at the same meter, Switches ar the inspiration of booster cable vocalizer and guitar player Matt Bishop. Bishop claims he was already writing songs on a bantam guitar made for him by his father (a BBC locomotive engine engineer) at the age of five, and began recording them on a Fisher-Price cassette machine, creating overdubs by playing second his creations on his mom's stereoscopic picture system and singing along with them. (Bishop adds that since he only knew two or trio chords at the sentence, most of these songs tended to resemble T. Rex.) As he grew sr., Bishop became an obsessive partizan of all things rock, and as a adolescent he graduated to a four-track porta-studio which he secondhand to proceed his experiments in unlocking the secrets of record book output. When he went away to college, Bishop began putt together a striation with like-minded classmates, and with Ollie Thomas on lead story guitar, Max Tite on bass, and Jimmy G on drums, Matt Rock and the Others was natural. In 2002, the chemical group s Korean south Korean won a university-sponsored Battle of the Bands, claiming identification number 1 award -- the opening slot on a countrywide go by the Darkness. Convinced they had a future on medicine, Bishop and his match fall by the wayside schoolhouse and resettled to Guildford, where they began severely working up songs and changed their name to Switches. After signing to the independent Degenerate Music label, the band recorded an eclecticist five-song demonstration and flew to the United States to represent a showcase at the South by Southwest Music Conference in Austin, TX. Between the demonstration and their manic animated show, Switches made a major impression on American A&R exercise force, and they sign a plow with Atlantic Records. Writing material in 'tween tours with the likes of Graham Coxon, Hard-Fi, the Rakes, and Louis XIV, Switches released their debut EP, Message from Yuz, in the summer of 2006. With ternion singles following in later 2006 and other 2007, Switches in conclusion released their first full album, Heart Tuned to D.E.A.D., on April 23, 2007. |
Monday, 8 September 2008
Mp3 music: Switches
Wednesday, 20 August 2008
BioSphere Medical Announces ACOG Practice Bulletin Recommendation Of Uterine Artery Embolization As Alternative To Hysterectomy
�BioSphere Medical, Inc. (NASDAQ:BSMD) - a medical twist company that has pioneered the purpose of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy - today announced that in its August Practice Bulletin, the American College of Obstetricians and Gynecologists (ACOG) recommended uterine artery embolization (UAE) (also known as UFE) as an alternate to hysterectomy in the management of leiomyomas (fibroids). The bulletin cites the availability of Level A research, which is based on "safe and logical scientific evidence" that shows that UAE "is a safe and effective option for befittingly selected women who wish to keep their uteri." The passport is likewise based on both retentive and short-term treatment outcomes.
"We are pleased UFE has obtained this crucial recognition, and believe it is a significant stride in the ongoing exploitation of the market for this minimally invasive, uterus-sparing alternative to hysterectomy," commented Richard J. Faleschini, president and CEO of BioSphere Medical. Mr. Faleschini continued, "Gynecologists ar one of the key providers in women's health. We think the new guidelines in this Practice Bulletin should result in more gynecologists discussing UFE as a mainstream handling option with their patients and forging collaborative relationships with interventional radiologists to optimize the quality of care offered to women with fibroids."
About BioSphere Medical, Inc.
BioSphere Medical, Inc. seeks to pioneer and commercialize minimally invasive diagnostic and therapeutic applications based on proprietary bioengineered microsphere technology. The Company's core technologies, patented bioengineered polymers and manufacturing methods, are put-upon to acquire microscopic globose materials with unique beneficial properties for a sort of medical applications. BioSphere's principal focus is the treatment of symptomatic uterine fibroids using a operation called uterine fibroid embolization, or UFE. The Company's products continue to gain acceptance in this rapidly emerging procedure, as advantageously as in a number of other new and established medical treatments. http://www.biospheremed.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding the expected favorable benefits of the ACOG Practice Bulletin on gynecologists' treatment and referral behaviors. The Company may use words such as "plans," "seeks," "projects," "believes," "may," "anticipates," "estimates," "should," "intends," "looking ahead," and similar expressions to identify these forward-looking statements. There ar a identification number of significant factors that may affect the Company's actual public presentation and results and the accuracy of its advanced statements, many of which are beyond the Company's control and are difficult to predict. These important factors include, without limitation, risks relating to: the failure of the Company to successfully develop, commercialize and attain widespread mart acceptance of its products; the failure of the Company to increase the rate of UFE procedures, and co-occurrence use of its products for UFE, with its expanded gross sales force and its of late initiated gross sales and selling strategies; the failure of the Company to attain or maintain necessary regulative approvals; the Company's power to obtain and sustain patent and other proprietary protection; the absence of, or delays or cancellations of, mathematical product orders, and delays, difficulties or unlooked-for costs in the creation of new products; private-enterprise pressures and the danger of product liability claims, either of which may impact grocery acceptance of products and adversely involve the Company's operating results; the inability of the Company to successfully execute on its plans and strategies for future increase; the unfitness of the Company to raise extra funds in the good term to finance the development, marketing, and gross sales of its products; general economic and market conditions, both domestically and abroad; and risk of exposure factors described in the section coroneted "Risk Factors" in the Company's Quarterly Report on Form 10-Q for the quarter complete June 30, 2008, as filed by the Company with the Securities and Exchange Commission, and described in other filings made by the Company from time to time with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company's estimates as of the date of this spillage. The Company anticipates that subsequent events and developments may crusade its innovative statements to change. The Company specifically disclaims whatever obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances after the date of this push release.
More info
"We are pleased UFE has obtained this crucial recognition, and believe it is a significant stride in the ongoing exploitation of the market for this minimally invasive, uterus-sparing alternative to hysterectomy," commented Richard J. Faleschini, president and CEO of BioSphere Medical. Mr. Faleschini continued, "Gynecologists ar one of the key providers in women's health. We think the new guidelines in this Practice Bulletin should result in more gynecologists discussing UFE as a mainstream handling option with their patients and forging collaborative relationships with interventional radiologists to optimize the quality of care offered to women with fibroids."
About BioSphere Medical, Inc.
BioSphere Medical, Inc. seeks to pioneer and commercialize minimally invasive diagnostic and therapeutic applications based on proprietary bioengineered microsphere technology. The Company's core technologies, patented bioengineered polymers and manufacturing methods, are put-upon to acquire microscopic globose materials with unique beneficial properties for a sort of medical applications. BioSphere's principal focus is the treatment of symptomatic uterine fibroids using a operation called uterine fibroid embolization, or UFE. The Company's products continue to gain acceptance in this rapidly emerging procedure, as advantageously as in a number of other new and established medical treatments. http://www.biospheremed.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding the expected favorable benefits of the ACOG Practice Bulletin on gynecologists' treatment and referral behaviors. The Company may use words such as "plans," "seeks," "projects," "believes," "may," "anticipates," "estimates," "should," "intends," "looking ahead," and similar expressions to identify these forward-looking statements. There ar a identification number of significant factors that may affect the Company's actual public presentation and results and the accuracy of its advanced statements, many of which are beyond the Company's control and are difficult to predict. These important factors include, without limitation, risks relating to: the failure of the Company to successfully develop, commercialize and attain widespread mart acceptance of its products; the failure of the Company to increase the rate of UFE procedures, and co-occurrence use of its products for UFE, with its expanded gross sales force and its of late initiated gross sales and selling strategies; the failure of the Company to attain or maintain necessary regulative approvals; the Company's power to obtain and sustain patent and other proprietary protection; the absence of, or delays or cancellations of, mathematical product orders, and delays, difficulties or unlooked-for costs in the creation of new products; private-enterprise pressures and the danger of product liability claims, either of which may impact grocery acceptance of products and adversely involve the Company's operating results; the inability of the Company to successfully execute on its plans and strategies for future increase; the unfitness of the Company to raise extra funds in the good term to finance the development, marketing, and gross sales of its products; general economic and market conditions, both domestically and abroad; and risk of exposure factors described in the section coroneted "Risk Factors" in the Company's Quarterly Report on Form 10-Q for the quarter complete June 30, 2008, as filed by the Company with the Securities and Exchange Commission, and described in other filings made by the Company from time to time with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company's estimates as of the date of this spillage. The Company anticipates that subsequent events and developments may crusade its innovative statements to change. The Company specifically disclaims whatever obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances after the date of this push release.
More info
Sunday, 10 August 2008
Tuesday, 1 July 2008
EQUIPTO and Andre Nickatina
Artist: EQUIPTO and Andre Nickatina
Genre(s):
Other
Discography:
Midnight Machine Gun Rhymes And Alibis
Year:
Tracks: 15
Thursday, 26 June 2008
Negative Theory
Artist: Negative Theory
Genre(s):
Metal: Death,Black
Discography:
Promo
Year: 2001
Tracks: 2
Coco D'or
Monday, 16 June 2008
Sex Pistols To Eclipse Rolling Stones' Ferry At Isle Of Wight Festival
Members of the Sex Pistols will fly to this weekend's Isle of Wight Festival in private helicopters , it's been revealed.
The band, who are headlining the event alongside Kaiser Chiefs and The Police, apparently decided they needed to arrive in style after hearing that last year's headliners, The Rolling Stones, arrived by charted ferry.
“There’s nothing to beat the view of the Isle Of Wight from the skies when you’re on your way to play to that fantastic crowd. Johnny and the band were well up for the idea of helicopters,” a source told the Daily Star.
The Isle of Wight Festival begins today and is seen by many as the official start to the UK festival season.
As Gigwise revealed yesterday (June 12th), forecasters are predicting a mixture of sunshine and showers for the weekend, and cooler temperatures than recent weeks.
Are you going to the festival? How are you getting there? Let us know by posting a comment below. Sign up to see your thoughts appear automatically.
For all the latest information on this summer's festivals, check out our new look Festival Guide.
See Also
Friday, 6 June 2008
Fines R Us
The Federal Communications Commission may fine toy retailer Toys 'R' Us $248,000
for "willfully and repeatedly" violating a requirement that they place a label on
analog-only TV sets warning consumers that they will not be able to receive signals
on them from February. The FCC said that it had issued eight warnings to the toy
chain warning that labels in large type must be prominently displayed next to all
analog-only sets. The commission also proposed a fine of $216,000 against another
retailer, Value City, which had previously received two warning notices.
13/05/2008
See Also
Subscribe to:
Posts (Atom)